Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)
Sábháilte in:
| Príomhchruthaitheoir: | |
|---|---|
| Údar corparáideach: | |
| Formáid: | Leictreonach Ríomhleabhar |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
New York :
Nova Biomedical Books,
c2010.
|
| Sraith: | Metabolic diseases--laboratory and clinical research series.
Novinka (Series) |
| Ábhair: | |
| Rochtain ar líne: | An electronic book accessible through the World Wide Web; click to view |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Clár na nÁbhar:
- NAFLD and insulin resistance (IR)
- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines
- Adiponectin and NASH
- TNF-[alpha] and NAFLD/NASH
- Leptin and NAFLD/NASH
- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH
- Iron overload and NAFLD/NASH
- Mitochondrial abnormalities and NAFLD/NASH
- Genetic influences in NAFLD/NASH
- Therapeutic strategy for NASH patients
- Natural history of NAFLD
- Conclusions.